Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Zimmer Holdings (NY:ZBH)

83.22 +0.79 (+0.96%)
Streaming Delayed Price Updated: 1:35 PM EDT, May 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Zimmer Holdings

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
News headline image
These Analysts Slash Their Forecasts On Zimmer Biomet Following Q1 Results ↗
Zimmer Biomet Holdings, Inc (NYSE:ZBH) reported strong Q1 earnings, beating estimates and raising guidance. Analysts maintain mixed views on stock. 
Via Benzinga
News headline image
ZBH Q1 Deep Dive: Sales Force Changes, Tech Investments, and Margin Expansion Shape Outlook
Medical device company Zimmer Biomet (NYSE:ZBH) reported Q1 CY2026 results exceeding the market’s revenue expectations, with sales up 9.3% year on year to $2... 
Via StockStory
Discover which S&P500 stocks are making waves on Tuesday. ↗
Via Chartmill
Which S&P500 stocks have an unusual volume on Tuesday? ↗
Via Chartmill
What's going on in today's session: S&P500 movers ↗
Via Chartmill
Gapping S&P500 stocks in Tuesday's session ↗
Via Chartmill
News headline image
Zimmer Biomet (ZBH) Q1 2026 Earnings Transcript ↗
Zimmer Biomet (ZBH) Q1 2026 Earnings Transcript 
Via The Motley Fool
Topics World Trade
News headline image
Zimmer Biomet’s (NYSE:ZBH) Q1 CY2026 Sales Beat Estimates
Medical device company Zimmer Biomet (NYSE:ZBH) reported revenue ahead of Wall Street’s expectations in Q1 CY2026, with sales up 9.3% year on year to $2.09 b... 
Via StockStory
Topics Earnings
News headline image
What To Expect From Zimmer Biomet’s (ZBH) Q1 Earnings
Medical device company Zimmer Biomet (NYSE:ZBH) will be announcing earnings results this Tuesday before market hours. Here’s what investors should know. Zimm... 
Via StockStory
Topics Artificial Intelligence
News headline image
1 S&P 500 Stock to Own for Decades and 2 We Find Risky
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all ... 
Via StockStory
Topics Stocks
News headline image
3 Mid-Cap Stocks We Keep Off Our Radar
Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. Howe... 
Via StockStory
Topics Bonds
News headline image
Zimmer Biomet (ZBH) Q4 2024 Earnings Transcript ↗
Zimmer Biomet (ZBH) Q4 2024 Earnings Transcript 
Via The Motley Fool
News headline image
QSM Asset Management Loads Up 611,000 Mobileye Shares ↗
Mobileye develops advanced driver assistance and autonomous driving technologies for global automotive manufacturers and suppliers. 
Via The Motley Fool
Topics Economy Regulatory Compliance Supply Chain
News headline image
A Fund Just Bet $5.7 Million on Robert Half -- Is the Staffing Sector Due for a Rebound? ↗
Robert Half Inc. provides staffing and risk consulting solutions globally to employers across diverse industries. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
QSM Asset Management Bets on Beaten-Down Manpower Group With New $5.9 Million Stake in ManpowerGroup ↗
ManpowerGroup provides staffing and HR solutions worldwide, serving clients in 75 countries. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
MedTech Surge and Oncology Resilience Drive Johnson & Johnson to Q1 Earnings Beat
In a resounding display of corporate resilience, Johnson & Johnson (NYSE:JNJ) reported first-quarter 2026 financial results that surpassed Wall Street expectations, signaling a successful navigation of... 
Via MarketMinute
Topics Bankruptcy Earnings Economy
News headline image
Organogenesis Clears Major FDA Hurdle: Path to First Non-Surgical Biologic for Knee Osteoarthritis Widens
CANTON, Mass. — In a milestone development for the regenerative medicine sector, Organogenesis Holdings Inc. (Nasdaq: ORGO) announced today that it has successfully concluded a pivotal Type B meeting... 
Via MarketMinute
News headline image
3 Cash-Producing Stocks We Keep Off Our Radar
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient... 
Via StockStory
News headline image
3 Value Stocks We Find Risky
Value investing has produced some of the world’s most famous investing billionaires, including Warren Buffett, David Einhorn, and Seth Klarman, who built the... 
Via StockStory
Topics Economy
These S&P500 stocks that are showing activity before the opening bell on Monday. ↗
Via Chartmill
News headline image
Does This $25 Million Bet on a Stock Down 61% Signal Turnaround Potential at $6? ↗
Organon & Co. develops branded and biosimilar therapies with a focus on women’s health and specialty pharmaceuticals. 
Via The Motley Fool
News headline image
Surgical Equipment & Consumables - Diversified Stocks Q4 In Review: Zimmer Biomet (NYSE:ZBH) Vs Peers
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking a... 
Via StockStory
Topics Artificial Intelligence Economy World Trade
News headline image
Stryker Corporation (SYK): Navigating Innovation and Resilience in the Wake of a Digital Crisis
As of March 16, 2026, the medical technology landscape is grappling with a stark reminder of the vulnerabilities inherent in the digital shift of healthcare. Stryker Corporation (NYSE: SYK), a global... 
Via Finterra
Topics Earnings Economy Hacking
News headline image
3 Healthcare Stocks We Think Twice About
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry... 
Via StockStory
News headline image
3 Reasons to Avoid ZBH and 1 Stock to Buy Instead
Over the past six months, Zimmer Biomet’s stock price fell to $99.27. Shareholders have lost 6.1% of their capital, which is disappointing considering the S&P 500 has climbed by 7.6%. This might have... 
Via StockStory
Topics Stocks
News headline image
3 Reasons to Avoid ZBH and 1 Stock to Buy Instead
Over the last six months, Zimmer Biomet’s shares have sunk to $98.28, producing a disappointing 5.8% loss - a stark contrast to the S&P 500’s 6.7% gain. This may have investors wondering how to... 
Via StockStory
Topics Stocks
News headline image
The Top 5 Analyst Questions From Zimmer Biomet’s Q4 Earnings Call
Zimmer Biomet’s fourth quarter results were greeted positively by the market, with management crediting strong execution in the U.S. and robust demand for recently launched products as key drivers. CEO... 
Via StockStory
Topics Earnings
News headline image
A Closer Look at Healthcare Sector Earnings: AZN vs. EW vs. ZBH ↗
Via MarketBeat
News headline image
ZBH Q4 Deep Dive: U.S. Salesforce Overhaul Drives Guidance Caution Amid Product Momentum
Medical device company Zimmer Biomet (NYSE:ZBH) reported Q4 CY2025 results topping the market’s revenue expectations, with sales up 10.9% year on year to $2.24 billion. Its non-GAAP profit of $2.42 per... 
Via StockStory
News headline image
Zimmer Biomet (ZBH) Q4 2025 Earnings Transcript ↗
Zimmer Biomet (ZBH) Q4 2025 Earnings Transcript 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.